Delivery Order SPE2DB22D3004-SPE2DB25FPN14
Award Date 2/13/25
Potential Completion Date 2/14/25
Potential Value $3.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,034.84 firm fixed-price delivery order contract is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has an ultimate completion date of May 19, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,592.50 firm fixed-price delivery order contract is for the supply of EMGALITY 120 MG/ML PENML, a specialty medication. The contract has an ultimate completion date of December 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, with ID SPE2DB24D2205|SPE2DB25FDXTJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,556.10 Firm Fixed Price Delivery Order contract is for the provision of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has a period of performance through February 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. government agency Defense Logistics Agency (DLA) awarded a $1,729.00 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a period of performance through February 18, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,156.64 firm-fixed-price delivery order is for the supply of EMGALITY 120 MG/ML PENML, a medication. The contract has a period of performance through March 12, 2025 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $2,074.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under Indefinite Delivery Contract (IDC) SPE2DB20D3101, is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has a firm fixed-price pricing type and a completion date of November 20, 2024. This award is not designated as a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.40 firm fixed price delivery order is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,671.20, is a Delivery Order contract with a Firm Fixed Price pricing type. The award has an ultimate completion date of November 15, 2024 and covers the procurement of EMGALITY 120 MG/ML PENML. This contract does not have a set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4566407720 EMGALITY 120 MG/ML PENML. The $2,005.44 firm fixed-price delivery order has an ultimate completion date of November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,731.84, is for the delivery of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of September 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...